$3.71 Billion is the total value of Perceptive Advisors's 109 reported holdings in Q3 2019. The portfolio turnover from Q2 2019 to Q3 2019 was 47.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $365,837,000 | +7.7% | 4,059,900 | +0.9% | 9.86% | +26.4% |
| GBT | Buy | GLOBAL BLOOD THERAPEUTICS INC | $285,090,000 | -6.2% | 5,875,726 | +1.7% | 7.68% | +10.2% |
| MRTX | Buy | MIRATI THERAPEUTICS INC | $258,241,000 | -13.5% | 3,314,606 | +14.3% | 6.96% | +1.5% |
| IOVA | Sell | IOVANCE BIOTHERAPEUTICS INC | $200,467,000 | -31.4% | 11,014,702 | -7.6% | 5.40% | -19.4% |
| FOLD | Buy | AMICUS THERAPEUTICS INC | $197,369,000 | -26.5% | 24,609,700 | +14.4% | 5.32% | -13.7% |
| BBIO | BRIDGEBIO PHARMA INC | $143,983,000 | -20.4% | 6,706,268 | 0.0% | 3.88% | -6.5% | |
| ZGNX | Sell | ZOGENIX INC | $130,696,000 | -22.0% | 3,264,152 | -6.9% | 3.52% | -8.4% |
| ATNX | Buy | ATHENEX INC | $130,594,000 | -30.4% | 10,735,245 | +9.3% | 3.52% | -18.3% |
| AMRN | Buy | AMARIN CORPORATION PLCspons adr new | $115,763,000 | -3.7% | 7,636,079 | +23.1% | 3.12% | +13.0% |
| DOVA | Buy | DOVA PHARMACEUTICALS INC | $103,658,000 | +106.9% | 3,708,705 | +4.4% | 2.79% | +142.9% |
| MGTX | Buy | MEIRAGTX HOLDINGS PLC | $102,610,000 | -34.1% | 6,433,277 | +7.1% | 2.76% | -22.7% |
| QTNT | QUOTIENT LTD | $83,830,000 | -16.9% | 10,789,054 | 0.0% | 2.26% | -2.5% | |
| NVRO | Sell | NEVRO CORP | $83,801,000 | +13.6% | 974,773 | -14.3% | 2.26% | +33.4% |
| SLDB | Buy | SOLID BIOSCIENCES INC | $69,792,000 | +209.1% | 6,749,803 | +71.9% | 1.88% | +262.9% |
| SWTX | New | SPRINGWORKS THERAPEUTICS INC | $69,755,000 | – | 3,217,522 | +100.0% | 1.88% | – |
| BPMC | Sell | BLUEPRINT MEDICINES CORP | $64,893,000 | -43.3% | 883,264 | -27.2% | 1.75% | -33.4% |
| ZYME | Buy | ZYMEWORKS INC | $59,244,000 | +13.7% | 2,388,890 | +0.8% | 1.60% | +33.4% |
| MYOK | Buy | MYOKARDIA INC | $58,956,000 | +6.8% | 1,130,511 | +2.7% | 1.59% | +25.4% |
| ADMA | ADMA BIOLOGICS INC | $51,268,000 | +15.0% | 11,521,102 | 0.0% | 1.38% | +35.0% | |
| VRCA | VERRICA PHARMACEUTICALS INC | $50,337,000 | +27.0% | 3,410,412 | 0.0% | 1.36% | +49.2% | |
| NEPT | Buy | NEPTUNE WELLNESS SOLUTIONS INC | $47,835,000 | +59.6% | 13,436,906 | +51.1% | 1.29% | +87.4% |
| VBIV | Buy | VBI VACCINES INC | $45,951,000 | +86.7% | 45,951,556 | +77.1% | 1.24% | +119.1% |
| KOD | KODIAK SCIENCES INC | $45,084,000 | +22.9% | 3,135,199 | 0.0% | 1.22% | +44.3% | |
| ARNA | Sell | ARENA PHARMACEUTICALS INC | $43,624,000 | -46.1% | 953,129 | -30.9% | 1.18% | -36.7% |
| ALLO | ALLOGENE THERAPEUTICS INC | $42,075,000 | +1.5% | 1,543,790 | 0.0% | 1.13% | +19.2% | |
| CRNX | CRINETICS PHARMACEUTICALS INC | $38,922,000 | -39.8% | 2,587,953 | 0.0% | 1.05% | -29.4% | |
| RTRX | Sell | RETROPHIN INC | $37,905,000 | -50.0% | 3,270,571 | -13.3% | 1.02% | -41.3% |
| MNTA | MOMENTA PHARMACEUTICALS INC | $37,649,000 | +4.1% | 2,905,000 | 0.0% | 1.01% | +22.2% | |
| ALBO | ALBIREO PHARMA INC | $34,087,000 | -38.0% | 1,704,330 | 0.0% | 0.92% | -27.2% | |
| FOMX | Buy | FOAMIX PHARMACEUTICALS LTD | $34,060,000 | +207.0% | 11,203,881 | +140.3% | 0.92% | +260.0% |
| ONCE | SPARK THERAPEUTICS INC | $33,943,000 | -5.3% | 350,000 | 0.0% | 0.91% | +11.2% | |
| KDMN | KADMON HOLDINGS INC | $33,177,000 | +22.3% | 13,165,746 | 0.0% | 0.89% | +43.7% | |
| DBVT | DBV TECHNOLOGIES SAsponsored adr | $31,038,000 | +4.6% | 3,609,084 | 0.0% | 0.84% | +22.8% | |
| PROTAGONIST THERAPEUTICS INC | $24,876,000 | -0.8% | 2,071,297 | 0.0% | 0.67% | +16.3% | ||
| EIDX | EIDOS THERAPEUTICS INC | $24,711,000 | +15.7% | 686,992 | 0.0% | 0.67% | +35.9% | |
| CTMX | Buy | CYTOMX THERAPEUTICS INC | $24,014,000 | -32.1% | 3,253,923 | +3.2% | 0.65% | -20.3% |
| ESTA | ESTABLISHMENT LABS HOLDINGS INC | $23,836,000 | -14.0% | 1,260,528 | 0.0% | 0.64% | +0.9% | |
| NVTA | Sell | INVITAE CORP | $23,088,000 | -26.9% | 1,198,182 | -10.8% | 0.62% | -14.1% |
| RCKT | ROCKET PHARMACEUTICALS INC | $23,037,000 | -22.3% | 1,977,412 | 0.0% | 0.62% | -8.8% | |
| TPTX | Buy | TURNING POINT THERAPEUTICS I | $22,454,000 | +29.8% | 597,190 | +40.5% | 0.60% | +52.4% |
| YMAB | New | Y-MABS THERAPEUTICS INC | $22,280,000 | – | 854,940 | +100.0% | 0.60% | – |
| RGNX | Sell | REGENXBIO INC | $21,645,000 | -56.6% | 608,000 | -37.4% | 0.58% | -49.1% |
| BIO | New | BIO-RAD LABORATORIES INC SHS-A- | $21,628,000 | – | 65,000 | +100.0% | 0.58% | – |
| UROV | Buy | UROVANT SCIENCES LTD | $21,275,000 | +43.4% | 2,246,547 | +19.8% | 0.57% | +68.5% |
| EHTH | Sell | EHEALTH INC | $17,037,000 | -48.7% | 255,089 | -33.9% | 0.46% | -39.8% |
| VAPO | Buy | VAPOTHERM INC | $16,709,000 | -48.3% | 1,764,470 | +25.6% | 0.45% | -39.3% |
| ALDX | ALDEYRA THERAPEUTICS INC | $16,260,000 | -12.2% | 3,085,458 | 0.0% | 0.44% | +3.1% | |
| MMSI | Sell | MERIT MEDICAL SYSTEMS INC | $16,107,000 | -66.9% | 528,788 | -35.3% | 0.43% | -61.1% |
| STOK | STOKE THERAPEUTICS DEAL SHARES | $14,440,000 | -26.3% | 671,978 | 0.0% | 0.39% | -13.6% | |
| MTEM | MOLECULAR TEMPLATES INC | $13,010,000 | -21.1% | 1,974,133 | 0.0% | 0.35% | -7.1% | |
| CNCE | Sell | CONCERT PHARMACEUTICALS INC | $12,904,000 | -51.2% | 2,194,641 | -0.5% | 0.35% | -42.7% |
| AGRX | Buy | AGILE THERAPEUTICS INC | $12,711,000 | +21.7% | 10,726,750 | +27.3% | 0.34% | +42.5% |
| MORF | MORPHIC HOLDING INC | $11,772,000 | -8.6% | 650,000 | 0.0% | 0.32% | +7.1% | |
| TXG | New | 10X GENOMICS INC | $11,088,000 | – | 220,000 | +100.0% | 0.30% | – |
| SCPEU | New | SC HEALTH CORPunit 99/99/9999 | $10,350,000 | – | 1,000,000 | +100.0% | 0.28% | – |
| MRKR | MARKER THERAPEUTICS INC | $10,220,000 | -35.5% | 2,000,000 | 0.0% | 0.28% | -24.2% | |
| IDYA | IDEAYA BIOSCIENCES INC | $9,584,000 | -15.7% | 1,141,484 | 0.0% | 0.26% | -1.1% | |
| ADPT | Buy | ADAPTIVE BIOTECHNOLOGIES COR | $9,116,000 | -33.8% | 295,000 | +3.5% | 0.25% | -22.2% |
| MOTS | MOTUS GI HLDGS INC | $8,336,000 | -34.7% | 4,210,542 | 0.0% | 0.22% | -23.2% | |
| CBAY | Sell | CYMABAY THERAPEUTICS INC | $7,784,000 | -71.9% | 1,520,355 | -60.6% | 0.21% | -66.9% |
| MEIP | MEI PHARMA INC | $7,392,000 | -32.8% | 4,400,440 | 0.0% | 0.20% | -21.0% | |
| ALEC | ALECTOR INC | $7,379,000 | -20.9% | 511,731 | 0.0% | 0.20% | -7.0% | |
| New | TELADOC HEALTH INCnote 1.375% 5/1 | $7,398,000 | – | 5,000,000 | +100.0% | 0.20% | – | |
| VRAY | Sell | VIEWRAY INC | $7,110,000 | -85.2% | 2,451,748 | -55.1% | 0.19% | -82.6% |
| ZBH | New | ZIMMER BIOMET HLDGS INC | $6,864,000 | – | 50,000 | +100.0% | 0.18% | – |
| AQUESTIVE THERAPEUTICS INC | $6,720,000 | -24.3% | 2,113,400 | 0.0% | 0.18% | -11.3% | ||
| HCAT | New | HEALTH CATALYST INC | $6,674,000 | – | 210,924 | +100.0% | 0.18% | – |
| ICPT | INTERCEPT PHARMACEUTICALS INC | $6,477,000 | -16.6% | 97,600 | 0.0% | 0.17% | -2.2% | |
| ORTX | ORCHARD THERAPETICS PLCads | $6,198,000 | -15.1% | 521,800 | 0.0% | 0.17% | 0.0% | |
| SIC | New | SELECT INTERIOR CONCEPTS INCcl a | $5,707,000 | – | 440,000 | +100.0% | 0.15% | – |
| PRVB | New | PROVENTION BIO INC | $4,548,000 | – | 666,322 | +100.0% | 0.12% | – |
| CERN | New | CERNER CORP | $4,431,000 | – | 65,000 | +100.0% | 0.12% | – |
| HSACU | HEALTH SCIENCES ACQUISITIONS CORPunit 04/01/2024 | $4,292,000 | +1.2% | 400,000 | 0.0% | 0.12% | +19.6% | |
| TBIO | TRANSLATE BIO INC | $4,311,000 | -21.5% | 435,000 | 0.0% | 0.12% | -7.9% | |
| ATEC | New | ALPHATEC HOLDINGS INC | $4,267,000 | – | 850,000 | +100.0% | 0.12% | – |
| FULC | New | FULCRUM THERAPEUTICS INC | $3,984,000 | – | 600,000 | +100.0% | 0.11% | – |
| VERU | Buy | VERU INC | $3,564,000 | +15.8% | 1,650,000 | +14.2% | 0.10% | +35.2% |
| TWST | Buy | TWIST BIOSCIENCE CORP | $3,483,000 | +8.3% | 145,856 | +31.6% | 0.09% | +27.0% |
| ACST | ACASTI PHARMA INCcl a new | $3,364,000 | +65.8% | 1,779,882 | 0.0% | 0.09% | +93.6% | |
| BGNE | New | BEIGENE LTDput | $2,698,000 | – | 400,000 | +100.0% | 0.07% | – |
| VCRA | Sell | VOCERA COMMUNICATIONS INC | $2,460,000 | -60.4% | 99,804 | -48.7% | 0.07% | -53.5% |
| CORV | New | CORREVIO PHARMA CORP | $2,000,000 | – | 1,000,000 | +100.0% | 0.05% | – |
| XBI | Buy | SPDR SERIES TRUSTput | $1,604,000 | +2191.4% | 900,000 | +350.0% | 0.04% | +2050.0% |
| SGEN | New | SEATTLE GENETICS INC | $1,452,000 | – | 17,000 | +100.0% | 0.04% | – |
| EIGR | EIGER BIOPHARMACEUTICALS INC | $1,433,000 | -3.3% | 139,890 | 0.0% | 0.04% | +14.7% | |
| CRY | CRYOLIFE INC | $1,358,000 | -9.3% | 50,000 | 0.0% | 0.04% | +8.8% | |
| AXSM | AXSOME THERAPEUTICS INC | $1,091,000 | -21.3% | 53,879 | 0.0% | 0.03% | -9.4% | |
| SRRA | SIERRA ONCOLOGY INC | $1,041,000 | -30.3% | 2,666,190 | 0.0% | 0.03% | -17.6% | |
| MDCO | MEDICINES CO | $977,000 | +37.2% | 19,532 | 0.0% | 0.03% | +62.5% | |
| RACE | FERRARI N.V. | $955,000 | -4.6% | 6,200 | 0.0% | 0.03% | +13.0% | |
| ARWR | Sell | ARROWHEAD PHARMACEUTICALS INC | $866,000 | -90.1% | 30,738 | -90.7% | 0.02% | -88.6% |
| FIAT CHRYSLER AUTOMOBILES N | $802,000 | -92.0% | 62,000 | 0.0% | 0.02% | -90.4% | ||
| BMRN | New | BIOMARIN PHARMACEUTICAL INCput | $750,000 | – | 200,000 | +100.0% | 0.02% | – |
| NVCR | New | NOVOCURE LTD | $710,000 | – | 9,489 | +100.0% | 0.02% | – |
| ZYNE | New | ZYNERBA PHARMACEUTICALS INCput | $635,000 | – | 200,000 | +100.0% | 0.02% | – |
| MEDP | New | MEDPACE HLDGS INC | $532,000 | – | 6,328 | +100.0% | 0.01% | – |
| ALLK | New | ALLAKOS INC | $507,000 | – | 6,444 | +100.0% | 0.01% | – |
| ALNA | ALLENA PHARMACEUTICALS INC | $521,000 | -3.2% | 132,300 | 0.0% | 0.01% | +16.7% | |
| MREO | MEREO BIOPHARMA GROUP PLCads | $534,000 | +18.1% | 179,419 | 0.0% | 0.01% | +40.0% | |
| KPTI | New | KARYOPHARM THERAPEUTICS INC | $526,000 | – | 54,645 | +100.0% | 0.01% | – |
| NTRA | NATERA INC | $477,000 | +19.0% | 14,549 | 0.0% | 0.01% | +44.4% | |
| New | ARQULE INC | $391,000 | – | 54,500 | +100.0% | 0.01% | – | |
| GTHX | New | G1 THERAPEUTICS INC | $358,000 | – | 15,702 | +100.0% | 0.01% | – |
| TNDM | TANDEM DIABETES CARE INC | $379,000 | -8.5% | 6,422 | 0.0% | 0.01% | +11.1% | |
| RARX | New | RA PHARMACEUTICALS INC | $342,000 | – | 14,455 | +100.0% | 0.01% | – |
| MRTX | New | MIRATI THERAPEUTICS INCput | $145,000 | – | 100,000 | +100.0% | 0.00% | – |
| ABEOW | ABEONA THERAPEUTICS INCw exp 12/24/201 | $145,000 | -76.6% | 659,636 | 0.0% | 0.00% | -71.4% | |
| CFMS | New | CONFORMIS INC | $93,000 | – | 50,000 | +100.0% | 0.00% | – |
| OTLKW | OUTLOOK THERAPEUTICS INC*w exp 02/18/202 | $48,000 | +4.3% | 420,875 | 0.0% | 0.00% | 0.0% | |
| SLDB | Exit | SOLID BIOSCIENCES INCcall | $0 | – | -200 | -100.0% | -0.00% | – |
| BIIB | Exit | BIOGEN INCcall | $0 | – | -200,000 | -100.0% | -0.00% | – |
| Exit | CONFORMIS INC | $0 | – | -100,000 | -100.0% | -0.01% | – | |
| ZIOP | Exit | ZIOPHARM ONCOLOGY INC | $0 | – | -90,498 | -100.0% | -0.01% | – |
| FLDM | Exit | FLUIDIGM CORP | $0 | – | -46,030 | -100.0% | -0.01% | – |
| GH | Exit | GUARDANT HEALTH INC | $0 | – | -6,617 | -100.0% | -0.01% | – |
| VYGR | Exit | VOYAGER THERAPEUTICS INC | $0 | – | -36,573 | -100.0% | -0.02% | – |
| RMTI | Exit | ROCKWELL MEDICAL INC | $0 | – | -1,500,000 | -100.0% | -0.10% | – |
| RYTM | Exit | RHYTHM PHARMACEUTICALS INC | $0 | – | -262,970 | -100.0% | -0.13% | – |
| THC | Exit | TENET HEALTHCARE CORP | $0 | – | -300,633 | -100.0% | -0.14% | – |
| SYBX | Exit | SYNLOGIC INC | $0 | – | -867,852 | -100.0% | -0.18% | – |
| MCRB | Exit | SERES THERAPEUTICS INC | $0 | – | -2,500,000 | -100.0% | -0.18% | – |
| SWAV | Exit | SHOCKWAVE MEDICAL INC | $0 | – | -150,000 | -100.0% | -0.20% | – |
| ACOR | Exit | ACORDA THERAPEUTICS INC | $0 | – | -1,127,318 | -100.0% | -0.20% | – |
| DXCM | Exit | DEXCOM INC | $0 | – | -60,000 | -100.0% | -0.21% | – |
| Exit | ANI PHARMACEUTICALS INCnote 3.000% 12/0 | $0 | – | -7,500,000 | -100.0% | -0.21% | – | |
| AXNX | Exit | AXONICS MODULATION TECHNOLOGIES INC | $0 | – | -285,502 | -100.0% | -0.27% | – |
| BHC | Exit | BAUSCH HEALTH COS INC | $0 | – | -600,000 | -100.0% | -0.35% | – |
| TDOC | Exit | TELADOC HEALTH INC | $0 | – | -307,021 | -100.0% | -0.47% | – |
| QURE | Exit | UNIQURE N.V | $0 | – | -281,820 | -100.0% | -0.50% | – |
| ARRY | Exit | ARRAY BIOPHARMA INC | $0 | – | -1,038,390 | -100.0% | -1.10% | – |
| ASND | Exit | ASCENDIS PHARMA A Ssponsored adr | $0 | – | -473,475 | -100.0% | -1.25% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-11-14
About Perceptive Advisors
Perceptive Advisors is a New York-based hedge fund that specializes in healthcare investments. The company was founded in 1999 by Joseph Edelman, who serves as the CEO and Chief Investment Officer. Since its inception, Perceptive Advisors has become one of the most successful healthcare-focused hedge funds in the world, with over $5 billion in assets under management.
The company's investment strategy is based on a deep understanding of the healthcare industry and a focus on identifying promising companies with innovative products and technologies. Perceptive Advisors invests in a wide range of healthcare sectors, including biotechnology, pharmaceuticals, medical devices, and healthcare services.
One of the key factors behind Perceptive Advisors' success is its team of experienced professionals. In addition to Joseph Edelman, the company's leadership team includes Adam Stone, the COO, and Jeremy Goldberg, the Chief Scientific Officer. The team also includes a group of highly skilled analysts and researchers who are experts in their respective fields.
Perceptive Advisors has a strong track record of generating high returns for its investors. However, it is important to note that investing in hedge funds carries significant risks, and investors should carefully consider their investment objectives and risk tolerance before investing. As with any investment, it is important to conduct thorough research and seek the advice of a qualified financial advisor before making any investment decisions.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| NEUROCRINE BIOSCIENCES SHARES | 42 | Q3 2023 | 15.7% |
| AMICUS THERAPEUTICS SHARES | 39 | Q3 2023 | 14.0% |
| ALDEYRA THERAPEUTICS SHARES | 35 | Q3 2023 | 3.3% |
| QUOTIENT TECHNOLOGY INC | 34 | Q3 2022 | 2.7% |
| GLOBAL BLOOD THERAPEUTICS SHARES | 29 | Q3 2022 | 9.3% |
| ADMA BIOLOGICS SHARES | 29 | Q3 2023 | 1.4% |
| RETROPHIN SHARES | 28 | Q3 2020 | 5.5% |
| DBV TECHNOLOGIES SA-SPON ADR | 28 | Q3 2021 | 1.8% |
| VBI VACCINES SHARES | 27 | Q1 2023 | 2.8% |
| IOVANCE BIOTHERAPEUTICS INC | 26 | Q3 2023 | 9.1% |
View Perceptive Advisors's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| CHEMBIO DIAGNOSTICS, INC.Sold out | May 04, 2023 | 0 | 0.0% |
| VBI Vaccines Inc/BC | April 07, 2023 | 43,509,553 | 16.7% |
| Landos Biopharma, Inc. | March 30, 2023 | 14,869,915 | 47.7% |
| REATA PHARMACEUTICALS INC | March 07, 2023 | 2,083,799 | 6.5% |
| AGILE THERAPEUTICS INCSold out | February 14, 2023 | 0 | 0.0% |
| ALBIREO PHARMA, INC. | February 14, 2023 | 1,757,160 | 8.5% |
| BELLUS Health Inc. | February 14, 2023 | 8,891,027 | 7.1% |
| CinCor Pharma, Inc. | February 14, 2023 | 2,576,325 | 5.9% |
| Coherus BioSciences, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| CONCERT PHARMACEUTICALS, INC. | February 14, 2023 | 1,800,000 | 3.6% |
View Perceptive Advisors's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-04-17 |
| SC 13D/A | 2024-04-17 |
| 4 | 2024-04-15 |
| SC 13G/A | 2024-04-15 |
| SC 13G | 2024-04-15 |
| SC 13D/A | 2024-04-10 |
| 4 | 2024-04-08 |
| 4 | 2024-04-03 |
| SC 13D/A | 2024-04-03 |
| SC 13D | 2024-03-20 |
View Perceptive Advisors's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.